Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.70 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
| ▸ | PRKCA | P17252 | 2/20 | 0.43 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.43 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.43 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3503764 | 1.00 | LMNA (0.70) | LMNAMAPTMAPK1GPR84FFAR1 | |
| SCHEMBL1278227 | 1.00 | LMNA (0.70) | LMNAMAPTMAPK1GPR84FFAR1 | |
| SCHEMBL3503956 | 1.00 | LMNA (0.70) | LMNAMAPTMAPK1GPR84FFAR1 | |
| SCHEMBL28284361 | 1.00 | LMNA (0.70) | LMNAMAPTMAPK1GPR84FFAR1 | |
| SCHEMBL3504067 | 1.00 | LMNA (0.70) | LMNAMAPTMAPK1GPR84FFAR1 | |
| SCHEMBL3505201 | 0.98 | LMNA (0.67) | LMNAMAPTMAPK1GPR84FFAR1 | |
| Isopropyl Myristate SCHEMBL10717490 | 0.92 | LMNA (0.85) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| Isopropyl Myristate SCHEMBL5513841 | 0.92 | LMNA (0.85) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| Cetyl Alcohol SCHEMBL753660 | 0.92 | LMNA (0.85) | LMNAMAPTMAPK1ALDH1A1PRKCA | |
| Isopropyl Myristate SCHEMBL10382139 | 0.92 | LMNA (0.85) | LMNAMAPTMAPK1ALDH1A1PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114044886-B | Production method of polycaprolactone | 青岛科技大学 | 2023-08-29 | — | — | CN | claimed |
| CN-114044886-A | Production method of polycaprolactone | 青岛科技大学 | 2022-02-15 | — | — | CN | claimed |
| US-20170087154-A1 | DRY POWDER FORMULATION OF AZOLE DERIVATIVE FOR INHALATION | GALEPHAR PHARMACEUTICAL RESEARCH, INC. (US) | 2017-03-30 | — | — | US | claimed |
| EP-2601973-A1 | Dry powder formulation of azole derivative for inhalation | Laboratoires SMB SA (BE) | 2013-06-12 | — | — | EP | claimed |
| US-20240209160-A1 | POLYMERIC DISPERSANTS FROM PHENYL GLYCIDYL ETHER | STEPAN COMPANY | 2024-06-27 | — | — | US | disclosed |
| US-20230399457-A1 | Bioactive Synthetic Copolymer, Bioactive Macromolecule and Related Methods Thereof | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2023-12-14 | — | — | US | disclosed |
| CN-114044886-B | Production method of polycaprolactone | 青岛科技大学 | 2023-08-29 | — | — | CN | disclosed |
| CN-112898264-B | Method for preparing epsilon-caprolactone, 6-hydroxycaproic acid and esters thereof by using furan acetic acid and esters thereof | 中国科学院兰州化学物理研究所 | 2022-04-22 | — | — | CN | disclosed |
| CN-112851623-B | Method for preparing epsilon-caprolactone, 6-hydroxycaproic acid and ester thereof by using tetrahydrofurfuryl acetic acid and ester thereof | 中国科学院兰州化学物理研究所 | 2022-04-08 | — | — | CN | disclosed |
| CN-114044886-A | Production method of polycaprolactone | 青岛科技大学 | 2022-02-15 | — | — | CN | disclosed |
| CN-112898264-A | Method for preparing epsilon-caprolactone, 6-hydroxycaproic acid and esters thereof by using furan acetic acid and esters thereof | 中国科学院兰州化学物理研究所 | 2021-06-04 | — | — | CN | disclosed |
| CN-112851623-A | Method for preparing epsilon-caprolactone, 6-hydroxycaproic acid and ester thereof by using tetrahydrofurfuryl acetic acid and ester thereof | 中国科学院兰州化学物理研究所 | 2021-05-28 | — | — | CN | disclosed |
| WO-1994001113-A1 | OXYTOCIN ANTAGONIST | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1994-01-20 | — | — | WO | disclosed |
| US-5244898-A | Vasopressin antagonist | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-09-14 | — | — | US | disclosed |
| US-5225402-A | Vasopressin antagonist, vasodilation, hypotensive, diuretics and anticoagulants | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-07-06 | — | — | US | disclosed |
| EP-0514667-A1 | Benzazepin derivatives as vasopressin antagonists | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-11-25 | — | — | EP | disclosed |
| EP-0513387-A1 | ACTIVE OXYGEN INHIBITOR | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-11-19 | — | — | EP | disclosed |
| US-5068361-A | Cyclization, deesterification, esterification over a fixed bed or fluidized bed oxidic catalyst | BASF AKTIENGESELLSCHAFT (DE) | 1991-11-26 | — | — | US | disclosed |
| EP-0450097-A1 | BENZOHETEROCYCLIC COMPOUNDS. | OTSUKA PHARMA CO LTD (JP) | 1991-10-09 | — | — | EP | disclosed |
| WO-1991005549-A1 | BENZOHETEROCYCLIC COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-05-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240209160-A1 | POLYMERIC DISPERSANTS FROM PHENYL GLYCIDYL ETHER | TYR, PAOX, NAPEPLD | LMNA 4466/4885MAPT 1821/4885MAPK1 3009/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.